2013
DOI: 10.1016/j.neubiorev.2013.10.010
|View full text |Cite
|
Sign up to set email alerts
|

The forgotten APOE allele: A review of the evidence and suggested mechanisms for the protective effect of APOE ɛ2

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

7
147
1
2

Year Published

2015
2015
2020
2020

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 160 publications
(161 citation statements)
references
References 122 publications
7
147
1
2
Order By: Relevance
“…The e2 carriers were less likely to develop clinical dementia 15,16 and had greater cognitive reserve, 17 since APOE e2 may be neuroprotective. 17 However, e2 carriers also had more cortical amyloid plaques, 18 with elevated risks of cerebral amyloid angiopathy 17 and cortical infarctions.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…The e2 carriers were less likely to develop clinical dementia 15,16 and had greater cognitive reserve, 17 since APOE e2 may be neuroprotective. 17 However, e2 carriers also had more cortical amyloid plaques, 18 with elevated risks of cerebral amyloid angiopathy 17 and cortical infarctions.…”
Section: Discussionmentioning
confidence: 99%
“…The e2 carriers were less likely to develop clinical dementia 15,16 and had greater cognitive reserve, 17 since APOE e2 may be neuroprotective. 17 However, e2 carriers also had more cortical amyloid plaques, 18 with elevated risks of cerebral amyloid angiopathy 17 and cortical infarctions. 2 Furthermore, children carrying e2 performed worse on visuospatial tasks 12 and had thicker temporal cortices 5 than non-e2 carriers, similar to adults carrying e2 with mild cognitive impairment or AD.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…According to the presence or absence of the ɛ4 allele, participants were classified as APOE4 carriers or noncarriers (Table 1). The investigation did not include ɛ2 carriers due to its relatively selective role acting as a protective factor [37, 38] and since its prevalence in the population is low, we did not have a sufficient number of participants in our sample to form a group comparable to the groups of carriers and noncarriers of the ɛ4 allele. Demographic and relevant variables of APOE4 carriers and noncarriers are shown in Table 2.…”
Section: Methodsmentioning
confidence: 99%
“…The carriage of the APOE 4 allele has been related to an increased glial activation, oxidative stress, or neuronal injury [21], which could result in altered brain repair mechanisms and a less effective neural protection [22]. Furthermore, ApoE 3 is the normal and most common isoform among the population, and ApoE 2 has been linked to protection against AD and has been also suggested to have a positive influence on cognitive health [23].…”
Section: Introductionmentioning
confidence: 99%